Proteome Sciences plc (LON:PRM – Get Free Report) fell 9.8% during mid-day trading on Wednesday . The company traded as low as GBX 3.18 ($0.04) and last traded at GBX 3.18 ($0.04). 41,420 shares were traded during trading, a decline of 55% from the average session volume of 91,685 shares. The stock had previously closed at GBX 3.52 ($0.04).
Proteome Sciences Stock Up 40.4 %
The company has a market capitalization of £14.17 million, a P/E ratio of -480.00 and a beta of 0.07. The stock has a fifty day simple moving average of GBX 2.92 and a 200-day simple moving average of GBX 3.11.
Proteome Sciences Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Featured Articles
- Five stocks we like better than Proteome Sciences
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- What is the Euro STOXX 50 Index?
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
